Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients
NCT00335517 is an interventional trial sponsored by University of Rochester. As of 21 Nov 2026, it is completed. It studies DepoDur in Lumbar Spine Surgery. The registry lists an enrollment of 98 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2006 and a primary completion date of 30 Sept 2010.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00335517 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | University of Rochester |
| Enrollment | 98 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Lumbar Spine Surgery |
| Drugs | DepoDur |
| Start | 30 Jun 2006 |
| Primary completion | 30 Sept 2010 |
| Study completion | 30 Nov 2010 |
| Last update posted | 19 Dec 2014 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Rechtine Glenn, MD
University of Rochester
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Rochester Medical Center
Rochester
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00335517
Each answer restates registry values shown on this page.
What is NCT00335517?
NCT00335517 is an interventional trial sponsored by University of Rochester. It studies DepoDur in Lumbar Spine Surgery.
Who leads NCT00335517?
The registry names Rechtine Glenn, MD (principal investigator, University of Rochester) as the overall official.
Where does NCT00335517 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00335517 study?
The registered drug and biological interventions are DepoDur.
When did NCT00335517 end?
The registry lists a primary completion date of 30 Sept 2010 and a study completion date of 30 Nov 2010. The sponsor last updated the record on 19 Dec 2014.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.